Search Results - "Heroux, Julie"

Oral estradiol/micronized progesterone may be associated with lower risk of venous thromboembolism compared with conjugated equine estrogens/medroxyprogesterone acetate in real-world practice by Panay, Nick, Nappi, Rossella E., Stute, Petra, Palacios, Santiago, Paszkowski, Tomasz, Kagan, Risa, Archer, David F., Héroux, Julie, Boolell, Mitra

“…•Conjugated equine estrogens/medroxyprogesterone acetate (CEE/MPA) is associated with increased risk of venous thromboembolism (VTE).•VTE risk was compared for…”
Get full text

Treatment patterns of pediatric patients with atopic dermatitis: A claims data analysis by Paller, Amy S., Siegfried, Elaine C., Vekeman, Francis, Gadkari, Abhijit, Kaur, Mandeep, Mallya, Usha G., Héroux, Julie, Miao, Raymond, Mina-Osorio, Paola

“…Real-world evidence on treatment patterns of pediatric patients with atopic dermatitis (AD) is sparse. To assess current treatment patterns in pediatric AD…”
Get full text

Necrotic core thickness and positive arterial remodeling index: emergent biomechanical factors for evaluating the risk of plaque rupture by Ohayon, Jacques, Finet, Gérard, Gharib, Ahmed M, Herzka, Daniel A, Tracqui, Philippe, Heroux, Julie, Rioufol, Gilles, Kotys, Melanie S, Elagha, Abdalla, Pettigrew, Roderic I

“…Fibrous cap thickness is often considered as diagnostic of the degree of plaque instability. Necrotic core area (Core(area)) and the arterial remodeling index…”
Get more information

Effects of variations in access to care for children with atopic dermatitis by Siegfried, Elaine C, Paller, Amy S, Mina-Osorio, Paola, Vekeman, Francis, Kaur, Mandeep, Mallya, Usha G, Héroux, Julie, Miao, Raymond, Gadkari, Abhijit

“…An estimated 50% of children in the US are Medicaid-insured. Some of these patients have poor health literacy and limited access to medications and specialty…”
Get full text

Marginal structural models for skewed outcomes: identifying causal relationships in health care utilization by Héroux, Julie, Moodie, Erica E.M., Strumpf, Erin, Coyle, Natalie, Tousignant, Pierre, Diop, Mamadou

“…Evaluating the impacts of clinical or policy interventions on health care utilization requires addressing methodological challenges for causal inference while…”
Get full text

Fracture risk in women with osteoporosis initiated on gastro-resistant risedronate versus immediate release risedronate or alendronate: a claims data analysis in the USA by Eisman, John A., Cortet, Bernard, Boolell, Mitra, Ionescu-Ittu, Raluca, Vekeman, Francis, Heroux, Julie, Thomasius, Friederike

“…Summary The study results indicate that women with osteoporosis initiated on gastro-resistant risedronate have a lower risk of fracture than those initiated on…”
Get full text

Biomechanics of Atherosclerotic Coronary Plaque: Site, Stability and In Vivo Elasticity Modeling by Ohayon, Jacques, Finet, Gérard, Le Floc’h, Simon, Cloutier, Guy, Gharib, Ahmed M., Heroux, Julie, Pettigrew, Roderic I.

“…Coronary atheroma develop in local sites that are widely variable among patients and are considerably variable in their vulnerability for rupture. This article…”
Get full text

Five-Year Direct Cost of Pediatric Patients with Acute Lymphoblastic Leukemia (ALL) Undergoing Allogeneic Stem Cell Transplantation (HSCT): An Analysis from US Payers' Perspective by Maziarz, Richard T., Guerin, Annie, Gauthier, Genevieve, Heroux, Julie, Zhdanava, Maryia, Wu, Eric Q, Thomas, Simu K, Chen, Lei

“…Background: Between 54%-85% of pediatric patients (pts) with ALL can be cured by definitive chemotherapy protocols. HSCT may be considered for high-risk pts…”
Get full text

Real-world treatment patterns of gout patients treated with colchicine or other common treatments for gout in acute care settings: a retrospective chart review study by Shiozawa, Aki, Cloutier, Martin, Heroux, Julie, Guerin, Annie, Wu, Eric Q., Jackson, Robert

“…To describe real-world treatment patterns of patients receiving colchicine or other treatments during a gout-related emergency room or acute care facility…”
Get full text

Treatment Patterns, Resource Use, and Economic Outcomes Associated with Atypical Antipsychotic Prescriptions in Children and Adolescents with Attention-Deficit Hyperactivity Disorder in Quebec by Lachaine, Jean, De, Gourab, Sikirica, Vanja, van Stralen, Judy, Hodgkins, Paul, Yang, Hongbo, Heroux, Julie, Amor, Leila Ben

“…Objective: To assess treatment patterns, health care resource utilization (HRU), and costs among previously stimulant-treated children and adolescents with…”
Get full text

Is arterial wall-strain stiffening an additional process responsible for atherosclerosis in coronary bifurcations?: an in vivo study based on dynamic CT and MRI by Ohayon, Jacques, Gharib, Ahmed M, Garcia, Alberto, Heroux, Julie, Yazdani, Saami K, Malvè, Mauro, Tracqui, Philippe, Martinez, Miguel-Angel, Doblare, Manuel, Finet, Gérard, Pettigrew, Roderic I

“…Coronary bifurcations represent specific regions of the arterial tree that are susceptible to atherosclerotic lesions. While the effects of vessel compliance,…”
Get more information

Treatment Patterns, Resource Use, and Economic Outcomes Associated With Atypical Antipsychotic Prescriptions in Children and Adolescents With Attention-Deficit Hyperactivity Disorder in Quebec/Modèles de traitement, utilisation des ressources, et résultats économiques associés aux prescriptions d'antipsychotiques atypiques aux enfants et adolescents souffrant du trouble de déficit d'attention avec hyperactivité au Québec by Lachaine, Jean, De, Gourab, Sikirica, Vanja, van Stralen, Judy, Hodgkins, Paul, Yang, Hongbo, Heroux, Julie, Amor, Leila Ben

“…To assess treatment patterns, health care resource utilization (HRU), and costs among previously stimulant-treated children and adolescents with…”
Get full text

High-Affinity αvβ3 Integrin Targeted Optical Probe as a New Imaging Biomarker for Early Atherosclerosis: Initial Studies in Watanabe Rabbits by Heroux, Julie, Gharib, Ahmed M., Danthi, Narasimhan S., Cecchini, Sylvain, Ohayon, Jacques, Pettigrew, Roderic I.

“…Purpose A newly developed synthetic αvβ3 integrin targeted optical probe (ITOP) has been demonstrated to target cancer cells, in vivo . Compared to the…”
Get full text

Five-year direct costs of acute lymphoblastic leukemia pediatric patients undergoing allogeneic stem cell transplant by Maziarz, Richard T, Guérin, Annie, Gauthier, Geneviève, Heroux, Julie, Zhdanava, Maryia, Wu, Eric Q, Thomas, Simu K, Chen, Lei

“…To assess the 5-year healthcare resource utilization (HRU) and direct payer costs following allogeneic hematopoietic stem cell transplants (HSCTs) in acute…”
Get full text

Treatment compliance and venous thromboembolism risk in women receiving estradiol/micronised progesterone vs conjugated estrogens/medroxyprogesterone by Nappi, Rossella, Panay, Nick, Palacios, Santiago, Paszkowski, Tomasz, Héroux, Julie, Boolell, Mitra

Get full text

Profile order and time-dependent artifacts in contrast-enhanced coronary MR angiography at 3T: Origin and prevention by Kotys, Melanie S., Herzka, Daniel A., Vonken, Evert-Jan, Ohayon, Jacques, Heroux, Julie, Gharib, Ahmed M., Stuber, Matthias, Pettigrew, Roderic I.

“…To enhance the clinical value of coronary magnetic resonance angiography (MRA), high‐relaxivity contrast agents have recently been used at 3T. Here we examine…”
Get full text

High-Affinity alpha v beta 3 Integrin Targeted Optical Probe as a New Imaging Biomarker for Early Atherosclerosis: Initial Studies in Watanabe Rabbits by Heroux, Julie, Gharib, Ahmed M, Danthi, Narasimhan S, Cecchini, Sylvain, Ohayon, Jacques, Pettigrew, Roderic I

“…Purpose: A newly developed synthetic alpha v beta 3 integrin targeted optical probe (ITOP) has been demonstrated to target cancer cells, in vivo. Compared to…”
Get full text

High-Affinity [alpha]v[beta]3 Integrin Targeted Optical Probe as a New Imaging Biomarker for Early Atherosclerosis: Initial Studies in Watanabe Rabbits by Heroux, Julie, Gharib, Ahmed M, Danthi, Narasimhan S, Cecchini, Sylvain, Ohayon, Jacques, Pettigrew, Roderic I

“…A newly developed synthetic αvβ3 integrin targeted optical probe (ITOP) has been demonstrated to target cancer cells, in vivo. Compared to the commercially…”
Get full text

High-affinity alphavbeta3 integrin targeted optical probe as a new imaging biomarker for early atherosclerosis: initial studies in Watanabe rabbits by Heroux, Julie, Gharib, Ahmed M, Danthi, Narasimhan S, Cecchini, Sylvain, Ohayon, Jacques, Pettigrew, Roderic I

“…A newly developed synthetic alpha v beta 3 integrin targeted optical probe (ITOP) has been demonstrated to target cancer cells, in vivo. Compared to the…”
Get full text

Economic burden of relapsed/refractory chronic lymphocytic leukemia by Guerin, Annie, Ray, Saurabh, Gauthier, Geneviève, Hsu, Ling-I, Zhdanava, Maryia, Héroux, Julie, Wu, Eric Qiong

“…Abstract only…”
Get full text